Stephen Colagiuri

2 weeks ago | diabetesresearchclinicalpractice.com | Stephen Colagiuri |Antonio Ceriello

Get full text accessLog in, subscribe or purchase for full access. REFERENCES1. J Hepatol. 2024; 81:492-5422. Younossi, Z.M. ∙ Golabi, P. ∙ Paik, J.M. ... The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic reviewHepatology. 2023; 77:1335-13473. En Li Cho, E. ∙ Ang, C.Z. ∙ Quek, J. ... Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysisGut. 2023; 72:2138-21484.

2 weeks ago | diabetesresearchclinicalpractice.com | Stephen Colagiuri |Antonio Ceriello

Get full text accessLog in, subscribe or purchase for full access. REFERENCES1. Obesity and type 2 diabetes: a joint approach to halt the rise. A policy brief by the International Diabetes Federation and the World Obesity Federation. Available from: https://www.idf.org/media/uploads/2022/11/IDF-WOF-Obesity-and-type-2-diabetes_A-joint-approach-to-halt-the-rise-WEB-2.pdf [Accessed September 2024]. 2. World Obesity Federation. Missing the 2025 Global Targets.

2 weeks ago | diabetesresearchclinicalpractice.com | Antonio Ceriello |Stephen Colagiuri

Diabetes is a major global health challenge, with an estimated 589 million adults in 2024 living with diabetes, of whom almost one-in-two were undiagnosed. In addition, another 1.1 billion adults worldwide had impaired glucose tolerance or impaired fasting glycaemia predisposing them to an increased risk of developing type 2 diabetes mellitus (T2DM). These numbers are projected to increase significantly over the next two decades [1]

2 weeks ago | diabetesresearchclinicalpractice.com | Stephen Colagiuri |Antonio Ceriello

Get full text accessLog in, subscribe or purchase for full access. REFERENCES1. Ibrahim, M. ∙ Ba-Essa, E.M. ∙ Baker, J. ... Cardio-renal-metabolic disease in primary care settingDiabetes Metab Res Rev. 2024; 40:e37552. Bello, A.K. ∙ Levin, A. ∙ Tonelli, M. ... Assessment of global kidney health care statusJAMA. 2017; 317:1864-18813. World Health Organization. Web Annex A.

2 weeks ago | diabetesresearchclinicalpractice.com | Stephen Colagiuri |Antonio Ceriello

Get full text accessLog in, subscribe or purchase for full access. REFERENCES1. Holman, R.R. ∙ Paul, S.K. ∙ Bethel, M.A. ... 10-year follow-up of intensive glucose control in type 2 diabetesN Engl J Med. 2008; 359:1577-15892. Adler, A.I. ∙ Coleman, R.L. ∙ Leal, J. ... Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)Lancet. 2024; 404:145-1553. Adler, A.I. ∙ Stratton, I.M. ∙ Neil, H.A. ...